Improving Driving in Young People With Autism Spectrum Disorders



Status:Recruiting
Conditions:Neurology, Psychiatric, Psychiatric, Autism
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:18 - 24
Updated:11/8/2018
Start Date:October 31, 2018
End Date:June 15, 2020
Contact:Elizabeth Noyes, BA
Email:enoyes@partners.org
Phone:617-726-4651

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
This study will examine the effects of treatment with the anti-anxiety medicine buspirone on
driving performance (eye tracking) in individuals with high-functioning autism spectrum
disorder (HF-ASD).

The study consists of an Assessment Visit at Massachusetts General Hospital (MGH), as well as
two Driving Simulation visits that will take place at Massachusetts Institute of Technology
(MIT). Subjects will be given buspirone and asked to take the medication for the two days
preceding the Driving Simulation Visit.


Inclusion Criteria:

- Males and females, ages 18-24, with a diagnosis of DSM-V Autism Spectrum Disorder

- Has a valid Driver's License

Exclusion Criteria:

- Major sensorimotor handicaps (e.g. deafness, blindness)

- Individuals who have never held a valid driver's license

- Intellectual Deficiency (Verbal Comprehension Index < 80)

- Inadequate command of the English language

- Subjects with any clinically meaningful medical or psychiatric condition as determined
by the investigator

- Individuals who are currently taking a monoamine oxidase inhibitor (MAOI) for any
reason

- Pregnant
We found this trial at
1
site
Massachusetts General Hospital
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
Principal Investigator: Joseph Biederman, MD
Phone: 617-726-4641
?
mi
from
Boston, MA
Click here to add this to my saved trials